郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价A Novel Multifunctional Compound Camellikaempferoside B Decreases Aβ Production, Interferes with Aβ Aggregation, and Prohibits Aβ-Mediated Neurotoxicity and Neuroinflammation.

期刊：ACS chemical neuroscience发表年份：2016作者：Shigao Yang; Wen Liu; Shuai Lu; Yong-zhen Tian; Wei-yun Wang; Tie-jun Ling; Rui-tian Liu
阅读更多 →

药效评价Development of Leishmania donovani stably expressing DsRed for flow cytometry-based drug screening using chalcone thiazolyl-hydrazone as a new antileishmanial target.

期刊：International journal of antimicrobial agents发表年份：2016作者：Anil Kumar Jaiswal; K Bhaskara Rao; Pragati Kushwaha; Keerti Rawat; Ram K Modukuri; Prashant Khare; Sumit Joshi; Shikha Mishra; Ambak Rai; Koneni V Sashidhara; Anuradha Dube
阅读更多 →

药效评价High avidity chimeric monoclonal antibodies against the extracellular domains of human aquaporin-4 competing with the neuromyelitis optica autoantibody, NMO-IgG.

期刊：British journal of pharmacology发表年份：2016作者：Kaori Miyazaki-Komine; Yoshiki Takai; Ping Huang; Osamu Kusano-Arai; Hiroko Iwanari; Tatsuro Misu; Katsushi Koda; Katsuyuki Mitomo; Toshiko Sakihama; Yoshiaki Toyama; Kazuo Fujihara; Takao Hamakubo; Masato Yasui; Yoichiro Abe
阅读更多 →

药效评价Characterization of PCS1055, a novel muscarinic M4 receptor antagonist.

期刊：European journal of pharmacology发表年份：2016作者：Carrie H Croy; Wai Y Chan; Andrea M Castetter; Marla L Watt; Anne T Quets; Christian C Felder
阅读更多 →